PKO Investment Management Joint Stock Co Purchases 3,000 Shares of CVS Health Corporation $CVS

PKO Investment Management Joint Stock Co increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 9.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 33,300 shares of the pharmacy operator’s stock after acquiring an additional 3,000 shares during the quarter. PKO Investment Management Joint Stock Co’s holdings in CVS Health were worth $2,297,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in CVS. Sage Mountain Advisors LLC lifted its position in CVS Health by 30.8% during the 2nd quarter. Sage Mountain Advisors LLC now owns 9,478 shares of the pharmacy operator’s stock worth $654,000 after buying an additional 2,230 shares in the last quarter. DDD Partners LLC grew its stake in CVS Health by 2.5% in the second quarter. DDD Partners LLC now owns 184,959 shares of the pharmacy operator’s stock valued at $12,758,000 after purchasing an additional 4,517 shares in the last quarter. AlphaQuest LLC increased its position in shares of CVS Health by 59.5% during the 2nd quarter. AlphaQuest LLC now owns 6,057 shares of the pharmacy operator’s stock worth $418,000 after purchasing an additional 2,259 shares during the last quarter. Asset Management One Co. Ltd. increased its holdings in shares of CVS Health by 7.3% during the 2nd quarter. Asset Management One Co. Ltd. now owns 551,705 shares of the pharmacy operator’s stock worth $38,057,000 after acquiring an additional 37,350 shares during the last quarter. Finally, Avion Wealth increased its holdings in shares of CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 189 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have commented on CVS. Barclays upped their price objective on CVS Health from $80.00 to $87.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. The Goldman Sachs Group initiated coverage on CVS Health in a research note on Tuesday, October 14th. They issued a “buy” rating and a $91.00 price target for the company. Jefferies Financial Group boosted their price target on CVS Health from $80.00 to $92.00 in a research note on Wednesday, October 15th. Cantor Fitzgerald reissued an “overweight” rating and issued a $78.00 price objective on shares of CVS Health in a research note on Tuesday, August 26th. Finally, Bernstein Bank reduced their price objective on CVS Health from $78.00 to $72.00 and set a “market perform” rating for the company in a research note on Wednesday, July 16th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $83.38.

Insider Activity at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.22% of the stock is currently owned by insiders.

CVS Health Price Performance

Shares of NYSE CVS opened at $81.95 on Friday. The firm has a market capitalization of $103.94 billion, a P/E ratio of 22.89, a P/E/G ratio of 0.89 and a beta of 0.60. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74. The stock’s 50-day simple moving average is $75.57 and its two-hundred day simple moving average is $68.67. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $83.52.

CVS Health (NYSE:CVS) last issued its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.35. The company had revenue of $98.92 billion during the quarter, compared to analysts’ expectations of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.CVS Health’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date is Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is presently 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.